Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-329988
Filing Date
2021-11-15
Accepted
2021-11-15 16:38:53
Documents
10
Period of Report
2021-11-15

Document Format Files

Seq Description Document Type Size
1 6-K d261201d6k.htm 6-K 10453
2 EX-99.1 d261201dex991.htm EX-99.1 67921
3 EX-99.2 d261201dex992.htm EX-99.2 10948
4 GRAPHIC g261201dsp30.jpg GRAPHIC 3887
5 GRAPHIC g261201dsp38.jpg GRAPHIC 3827
6 GRAPHIC g261201g1115110438455.jpg GRAPHIC 6455
7 GRAPHIC g261201g1115110438993.jpg GRAPHIC 7291
8 GRAPHIC g261201g1115110439482.jpg GRAPHIC 9242
9 GRAPHIC g261201g1115110439880.jpg GRAPHIC 8080
10 GRAPHIC g261201g1115110440418.jpg GRAPHIC 40379
  Complete submission text file 0001193125-21-329988.txt   200529
Mailing Address LEVEL 12, 95 PITT STREET SYDNEY, NEW SOUTH WALES C3 2000
Business Address LEVEL 12, 95 PITT STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224
IMMUTEP Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-35428 | Film No.: 211411609
SIC: 2834 Pharmaceutical Preparations